RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLUE
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

bluebird bio stock price fell more than -5.35% Tuesday closing at $0.92
(Updated on Jul 02, 2024)

Sell candidate since Jul 01, 2024 Loss -5.35% PDF

The bluebird bio stock price fell by -5.35% on the last day (Tuesday, 2nd Jul 2024) from $0.98 to $0.92. During the last trading day the stock fluctuated 6.52% from a day low at $0.92 to a day high of $0.98. The price has fallen in 6 of the last 10 days and is down by -3.06% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -425 thousand shares and in total, 4 million shares were bought and sold for approximately $4.12 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.70% during the next 3 months and, with a 90% probability hold a price between $0.653 and $0.87 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLUE Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The bluebird bio stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.96 and $0.96. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 09, 2024, and so far it has fallen -17.58%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for bluebird bio stock

bluebird bio finds support from accumulated volume at $0.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0600 between high and low, or 6.52%. For the last week, the stock has had daily average volatility of 8.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLUE) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect bluebird bio to open at $0.94, and during the day (based on 14 day Average True Range), to move between $0.85 and $1.00, which gives a possible trading interval of +/-$0.0763 (+/-8.27%) up or down from last closing price. If bluebird bio takes out the full calculated possible swing range there will be an estimated 16.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.91 (1.35%) than the resistance at $1.00 (8.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is bluebird bio stock A Buy?

bluebird bio holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.590 Sell Candidate Unchanged

Predicted Opening Price for bluebird bio of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$0.94 ( 1.94%) $0.92

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLUE

Fibonacci Support & Resistance Levels

Level Price
R3 1.00 8.44%
R2 0.98 5.96%
R1 0.96 4.43%
Price 0.92
S1 0.92 -0.540%
S2 0.90 -2.07%
S3 0.88 -4.56%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.12 21.33%
R2 1.02 10.50%
R1 1.00 8.33%
Price 0.92
S1 0.91 -1.35%
S2 0.89 -3.90%
S3 0.85 -7.52%

FAQ

What is the symbol for bluebird bio Stock and on which exchange is it traded?
The symbol for bluebird bio is BLUE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell bluebird bio Stock?
bluebird bio holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy bluebird bio Stock?
bluebird bio Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy bluebird bio Stock.

What's the current price of bluebird bio Stock?
As of the end of day on the Jul 02, 2024, the price of an bluebird bio (BLUE) share was $0.92.

What is the 52-week high and low for bluebird bio Stock?
The 52-week high for bluebird bio Stock is $5.53 and the 52-week low is $0.85.

What is the market capitalization of bluebird bio Stock?
As of the Jul 02, 2024, the market capitalization of bluebird bio is 187.981M.

When is the next earnings date for bluebird bio?
The upcoming earnings date for bluebird bio is Aug 06, 2024.
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT